Clinical Trials Directory

Trials / Unknown

UnknownNCT04446156

Liver Diseases in PLWH

Epidemiological Investigation of HIV-infected Patients Complicated With Liver Disease in Zhejiang Province

Status
Unknown
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
First Affiliated Hospital of Zhejiang University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In Highly Active Antiretroviral Therapy era, fatty liver has become an important cause of liver function damage in people living with HIV (PLWH). There are a large number of PLWH in China who are infected with hepatitis B virus and hepatitis C virus. HIV, hepatitis B virus, hepatitis C virus, drugs, alcohol, etc. affect each other, which makes the cause, diagnosis, and treatment of liver function damage in PLWH complicated in China. The investigators plan to conduct a large-scale questionnaire survey among PLWH in Zhejiang Province to assess liver function, detect liver Injuries early, and analyze HIV, hepatitis B virus, hepatitis C virus, anti-HIV drugs, alcohol and other factors associate with liver injuries in PLWH, to provide basis for the treatment and prevention of liver disease in PLWH in eastern China.

Conditions

Timeline

Start date
2020-05-26
Primary completion
2020-08-31
Completion
2020-12-30
First posted
2020-06-24
Last updated
2020-06-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04446156. Inclusion in this directory is not an endorsement.